TMA updates Hassle Factor Log Form
Richardson, M.
Texas Medicine 89(4): 22-24
1993
ISSN/ISBN: 0040-4470 PMID: 8503100 Document Number: 419229
Document emailed within 1 workday
Related Documents
Tompkins, R.B. 1991: Easing the Medicare 'hassle factor' Minnesota Medicine 74(7): 41Kehrl, J.H.; Thevenin, C.; Rieckmann, P.; Fauci, A.S. 1991: Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA Journal of Immunology 146(11): 4016-4023
Burns, J. 2017: HEDIS Is the Hassle that Became a Habit Managed Care 26(1): 16-19
Hjemdahl, P. 1976: Seloken (Metoprolol, Hässle) Lakartidningen 73(12): 1092
Iwata, M.; Adachi, M.; Ishizaka, K. 1988: Antigen-specific T cells that form IgE-potentiating factor, IgG-potentiating factor, and antigen-specific glycosylation-enhancing factor on antigenic stimulation Journal of Immunology 140(8): 2534-2542
Johnson, C.E.; Newman, C.W.; Danhauer, J.L.; Williams, V.A. 2009: Eye on the elderly. Screening for hearing loss, risk of falls: a hassle-free approach Journal of Family Practice 58(9): 471-477
Dittert, L.W. 1976: Dosage form performance: a major factor in clinical medicine Connecticut Medicine 40(5): 333-337
de Vries-Smits, A.M.; Pronk, G.J.; Medema, J.P.; Burgering, B.M.; Bos, J.L. 1995: Shc associates with an unphosphorylated form of the p21ras guanine nucleotide exchange factor mSOS Oncogene 10(5): 919-925
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Muroya, K.; Hattori, S.; Nakamura, S. 1992: Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells Oncogene 7(2): 277-281
Murgue, B.; Tsunekawa, S.; Rosenberg, I.; deBeaumont, M.; Podolsky, D.K. 1994: Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium Cancer Research 54(19): 5206-5211
Giard, R.W. 1987: Which benign breast disorders form a risk factor for breast carcinoma ? Nederlands Tijdschrift Voor Geneeskunde 131(40): 1752-1754
Yamada, K.; Yamada, Z.; Nakazawa, S. 1970: Clinical evaluation of active and potentially active form of factor XIIi Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 33(5): 687-689
Partenheimer, A.; Schwarz, K.; Wrocklage, C.; Kölsch, E.; Kresse, H. 1995: Proteoglycan form of colony-stimulating factor-1 (proteoglycan-100). Stimulation of activity by glycosaminoglycan removal and proteolytic processing Journal of Immunology 155(12): 5557-5565
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Rugg, D. 2016: FY 2017 Updates to ICD-10-CM Journal of Ahima 87(11): 64-67
Turnbull, G.B. 2002: Reimbursement updates Ostomy/Wound Management 48(6): 8-9
Bonnefont, J.P.; Ogier, H.; Mitchell, G.; Demaugre, F.; Pelet, A.; Saudubray, J.M.; Frezal, J. 1985: Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT i in the hepatic form and CPT Ii in the muscular form Archives Francaises de Pediatrie 42(Suppl 1): 613-617
Hauk, L. 2017: CDC Updates Recommendations for Contraceptive Use American Family Physician 95(2): 125-126
Zeitlin, L.; Wientroub, S.; Blumberg, N. 2003: Updates in osteogenesis imperfecta Harefuah 142(10): 688-93 717